Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28368 | 170 | 26.2 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
702 | 12214 | TYPE 1 DIABETES//DIABETIC KETOACIDOSIS//BARBARA DAVIS CHILDHOOD DIABET |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FULMINANT TYPE 1 DIABETES | Author keyword | 71 | 84% | 22% | 38 |
2 | HEPATIC GLYCOGENOSIS | Author keyword | 9 | 83% | 3% | 5 |
3 | MAURIAC SYNDROME | Author keyword | 9 | 83% | 3% | 5 |
4 | GLYCOGENIC HEPATOPATHY | Author keyword | 8 | 100% | 3% | 5 |
5 | FULMINANT TYPE 1 DIABETES MELLITUS | Author keyword | 4 | 50% | 4% | 6 |
6 | TYPE 1B DIABETES | Author keyword | 3 | 50% | 2% | 4 |
7 | STEM CELL EDUCATOR THERAPY | Author keyword | 2 | 67% | 1% | 2 |
8 | METAB DIABET CLIN NUTR | Address | 2 | 20% | 6% | 10 |
9 | FULMINANT | Author keyword | 2 | 15% | 6% | 10 |
10 | GEN INTERNAL MED METAB | Address | 1 | 40% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RAPID ONSET | 4 | 18% | 12% | 21 |
2 | MAURIAC SYNDROME | 4 | 75% | 2% | 3 |
3 | HLA DQ GENOTYPE | 3 | 100% | 2% | 3 |
4 | HEPATIC GLYCOGENOSIS | 3 | 60% | 2% | 3 |
5 | GLYCOGENIC HEPATOPATHY | 2 | 50% | 2% | 3 |
6 | HEPATOSCLEROSIS | 1 | 100% | 1% | 2 |
7 | PERISINUSOIDAL FIBROSIS | 1 | 25% | 2% | 3 |
8 | 3A SUBSTRATE | 1 | 50% | 1% | 1 |
9 | F ACUMINATUM | 1 | 50% | 1% | 1 |
10 | SLOWLY PROGRESSIVE IDDM | 0 | 14% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners | 2007 | 42 | 25 | 56% |
Fulminant type 1 diabetes in China: a case report and review of the literature | 2010 | 1 | 11 | 100% |
Fulminant type 1 diabetes mellitus | 2006 | 16 | 21 | 57% |
Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes | 2013 | 6 | 55 | 20% |
Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide | 2008 | 0 | 7 | 43% |
Human cord blood stem cells and the journey to a cure for type 1 diabetes | 2010 | 9 | 38 | 11% |
Fulminant Type 1 Diabetes Mellitus and Fulminant Viral Myocarditis A Case Report and Literature Review | 2015 | 0 | 23 | 30% |
New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells | 2011 | 9 | 77 | 8% |
Fulminant diabetes mellitus associated with pregnancy: Case reports and literature review | 2002 | 6 | 7 | 14% |
Diabetes mellitus: Referential changes on the horizon not necessarily wellcome | 2010 | 0 | 10 | 10% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METAB DIABET CLIN NUTR | 2 | 20% | 5.9% | 10 |
2 | GEN INTERNAL MED METAB | 1 | 40% | 1.2% | 2 |
3 | INTERNAL MED MOL SCI B5 | 1 | 50% | 0.6% | 1 |
4 | SAN FRANCISCO DIABET | 1 | 50% | 0.6% | 1 |
5 | SECT BLOOD TRANSFUS | 1 | 50% | 0.6% | 1 |
6 | AN SEVERTSOV ECOL EVOLUT PROBLEMS | 0 | 33% | 0.6% | 1 |
7 | DIABET ENDOCRINOL METAB SECT | 0 | 33% | 0.6% | 1 |
8 | DIABETOL NEPHROL | 0 | 33% | 0.6% | 1 |
9 | MIL MED HRADEC KRALOVE | 0 | 33% | 0.6% | 1 |
10 | SIBERIAN STATE MED UNIV | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000167477 | ENCEPHALOMYOCARDITIS VIRUS//EMC D//IFIH1 |
2 | 0.0000133558 | ISLET CELL ANTIBODIES//IA 2//INSULIN AUTOANTIBODIES |
3 | 0.0000108672 | DIABETIC KETOACIDOSIS//KETOACIDOSIS//DKA |
4 | 0.0000066999 | IDDM2//INS VNTR//INSULIN GENE |
5 | 0.0000056038 | PROTEASE ANTIPROTEASE//RAT AND HUMAN ERYTHROCYTES//AFFECTED FACTOR |
6 | 0.0000055150 | BIOMED SURG CELL BIOL//MED CHILDRENS CLIN//RHIGF I THERAPY |
7 | 0.0000046285 | NON ALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC STEATOHEPATITIS//NASH |
8 | 0.0000043415 | PROINSULIN C PEPTIDE//C PEPTIDE//HUMAN C PEPTIDE |
9 | 0.0000042159 | PHOSPHORYLASE KINASE//PHOSPHORYLASE KINASE DEFICIENCY//GLYCOGEN STORAGE DISEASE TYPE IX |
10 | 0.0000041055 | NOD MOUSE//NOD MICE//JULIA MCFARLANE DIABET |